Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology
The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio's commercial platform.PLANO, Texas, Dec. 11, 2025 /PRNewswire/...